Transdermal Nanogel Therapy in the Management of Skin Cancer. Dieser Artikel ist nicht verfügbar.Transdermal Nanogel Therapy in the Management of Skin Cancer

The concept of this book is focused on transdermal Nanogel therapy against skin cancer. Skin cancer is the type of cancer which arises from skin, invades other part of the body and one of the most common types of cancer with increasing number of cases worldwide. From last few decades the advancement of transdermal drug delivery system is on the peak and when the disease needle pointed towards cancer especially skin cancer, transdermal delivery systems emerged as the first choice of treatment by virtue of patient compliance. Nanogels are the nano-sized system of their parent hydro gels, establishing high water uptake ability, swelling capability, degradability, pH-sensitivity and shows promising role in controlled delivery of therapeutics, delivery of cell, wound healing and tissue engineering. The prime objective of this silhouette was to investigate the anticancer potential of transdermal nanogel consisting anticancer drug against melanoma. The book highlights the enhanced onsite targeting potential of nanogel encapsulating anticancer drug offering offers patient compliance, decreasing dose frequency and opening novel avenue against treatment of skin cancer in clinical platform.

Dr Prashant Sahu is a CSIR-Research Associate in DOPS, Dr H.S. Gour University, Sagar, India. He obtained his PhD degree from the same university and completed his master's degree from SIPS college Sagar. He published 2 patents, 21 research article, 2 books, 5 book chapters and won several research paper awards including MPCST young scientist award